Literature DB >> 15008051

Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency.

Trabue D Bryans1, Carolyn Braithwaite, John Broad, James F Cooper, Kimbrell R Darnell, Victoria M Hitchins, Amy Jo Karren, Peter S Lee.   

Abstract

Since the mid-1970s the Limulus Amebocyte Lysate (LAL) assay has been used to test medical devices for bacterial endotoxins. The Association for the Advancement of Medical Instrumentation (AAMI) recently published a standard designated ANSI/AAMI ST 72: 2002, Bacterial Endotoxins--Test methodologies, routine monitoring, and alternatives to batch testing, which addresses LAL testing and associated issues. In order to perform the bacterial endotoxins test (BET), the test article must be extracted in an aqueous medium, with the extract being used as the test solution. In the early years of testing, and periodically throughout LAL test history, questions have arisen about validation of the extraction efficiency of endotoxins from medical devices. The AAMI Microbiological Methods Committee appointed a Task Group to thoroughly research the issue of extraction efficiency and to recommend whether validation of extraction efficiency is necessary for LAL testing of medical devices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008051     DOI: 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2

Source DB:  PubMed          Journal:  Biomed Instrum Technol        ISSN: 0899-8205


  4 in total

1.  A comparative study of blood endotoxin detection in haemodialysis patients.

Authors:  Jonathan Wong; Nathan Davies; Hasan Jeraj; Enric Vilar; Adie Viljoen; Ken Farrington
Journal:  J Inflamm (Lond)       Date:  2016-07-30       Impact factor: 4.981

2.  Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.

Authors:  Jonathan Wong; Yonglong Zhang; Ashish Patidar; Enric Vilar; Malcolm Finkelman; Ken Farrington
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

3.  Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery.

Authors:  Michail Yaroustovsky; Marina Plyushch; Dmitry Popov; Natalia Samsonova; Marina Abramyan; Zakhar Popok; Nickolay Krotenko
Journal:  J Inflamm (Lond)       Date:  2013-03-06       Impact factor: 4.981

4.  Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats.

Authors:  Laetitia Rodes; Shyamali Saha; Catherine Tomaro-Duchesneau; Satya Prakash
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.